Advanced search×

Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats.

Rui R Zhao, Wen-Zhen WZ Shi, Yong-Mei YM Zhang, San-Hua SH Fang, and Er-Qing EQ Wei

J Pharm Pharmacol 63(4):550-7 (2011) PMID 21401607

Previously we demonstrated the neuroprotective effect of montelukast, a cysteinyl leukotriene receptor-1 (CysLT(1) ) antagonist, on acute brain injury after focal cerebral ischaemia in mice. In this study, we have determined its effect on chronic brain injury after focal cerebral ischaemia in mice and rats.

DOI: 10.1111/j.2042-7158.2010.01238.x
Version: za2963e q8zac q8zba q8zc7 q8zda q8ze7 q8zfe q8zg3

Similar articles you may find interesting…

  1. A comparative study of peer and teacher feedback and of various peer feedback forms in a secondary school writing curriculum
    Sarah Gielen, Lies Tops, ... Stijn Smeets

    Br Educ Res J 36(1):143 (2010)

  2. Treatment of impacted greenstick forearm fractures in children using bandage or cast therapy: a prospective randomized trial.
    Rogier H J RH Kropman, Mike M Bemelman, ... Eric R ER Hammacher

    J Trauma 68(2):425-8 (2010) PMID 19935115

    : BT for impacted greenstick fractures of the distal forearm is a safe technique, patients treated with bandage suffer greater pain at the start of the treatment, are able to return to normal activities sooner, and have less discomfort when compared with the standard CT....
  3. Correspondence between stone composition and urine supersaturation in nephrolithiasis.
    J H JH Parks, M M Coward, and F L FL Coe

    Kidney Int 51(3):894-900 (1997) PMID 9067927

    We conclude that sparse urine SS measurements accurately track stone admixtures, and are a reliable index of average renal and urine SS....